Real world evidence extraction is one area where Sanofi is using NLP text mining, a technology with applications across the R&D pipeline, from target identification to clinical trial design and pharmacovigilance.
Amsbio is adding experimental cell lines to its CAR-T cell services to meet an increasing demand for the technology, according to the UK-based provider.
The new service from LabConnect, a central laboratory and support services provider, offers a global solution for sample preparation and processing requirements.
Studies are underway as the provider of genetically engineered rodent model solutions completes its most recent trip to the International Space Station.
PinneyAssociates and NMS Labs will plan, conduct, and analyze in vitro laboratory testing of pharmaceutical formulations to evaluate any abuse-deterrent properties, says CMO.
Key Biologics and Cascade Regional Blood Services’ multi-year agreement will provide researchers with the critical raw material needed for developing cell- and gene-based therapies.
Sanofi will use AbSci’s platform to further optimize two of its in-house proteins – and will partner with other companies to accelerate timelines and reduce costs.
AstraZeneca and Aptamer Group will collaborate to leverage Aptamer’s platform for targeted delivery of oligonucelotides to the kidney for therapeutic development.
University Hospitals Cleveland Medical Center has joined the TriNetX network to increase its research opportunities while benefitting the network of real world evidence and data.
